Owners of 10-year Treasury notes at recent 4.5% yields could reap up to 20% in a…
Author: Arthur Bleemer
Nike shares soar after earnings. Here’s why the athletic-gear giant expects the year to get better.
Nike on Thursday reported a first-quarter profit that beat expectations, although sales came up just shy…
‘The Golden Bachelor’ premieres: ‘How lucky would I be to find a second true love in my lifetime?’
ABC’s latest spin on the series highlights a 72-year-old bachelor and contestants in their 60s and…
‘Have we made a terrible mistake?’ My brother put our names on the deed to our 88-year-old mother’s home. What should we do?
‘The home is paid for in full, and she purchased it around 1995.’
Here are the ‘lottery’ winners of America’s housing market, according to Zillow’s chief economist
The housing market is at a standstill. But one group is in a very advantageous position.
‘It feels like a nightmare’: My siblings hid our father’s will, which would have left me $135,000. What can I do?
"I thought I could trust my own family, but now I realize I can trust no…
Following uproar, Delta CEO says airline went ‘too far’ with SkyMiles crackdown
Delta Air Lines’ CEO admitted on Monday the airline “probably went too far” in clamping down…
GOP presidential debate: DeSantis says Trump’s spending ‘set the stage for the inflation that we have now’
The comments came Wednesday during the 2024 GOP presidential primary's second debate, held at the Ronald…
Gas tax a target at Republican debate. Here’s what you’re paying now.
Nikki Haley wants to eliminate the federal gasoline tax. So, how much would that save you?
Micron’s AI-focused chip won’t help financial results anytime soon
CEO expects 'several hundreds million dollars' in annual revenue -- but not for a while
Trump attacks Biden over EVs as he makes pitch to auto workers
Donald Trump attacked President Biden over electric vehicles, skipping the second GOP presidential debate to make…
FDA panel rejects ALS treatment from Brainstorm Cell Therapeutics
A U.S. Food and Drug Administration advisory committee voted against a treatment from BrainStorm Cell Therapeutics…